HLA-DQA1*05 ALLELE CARRAIGE AND ANTI-TNF THERAPY PERSISTENCE IN INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Doherty, Jayne
Ryan, Anthony W.
Quinn, Emma
Dolan, Jackie
Corcoran, Roisin
O'Hara, Fintan
Bailey, Yvonne
Mcnamara, Deirdre
Doherty, Glen
Kevans, David
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1796
引用
收藏
页码：S435 / S436
页数：2
相关论文
共 50 条
  • [21] Carriage of the HLA-DQA1☆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease
    Hernandez, Pilar Navajas
    el Halabi, Samer Mouhtar
    Parra, Ana Caridad Gonzalez
    Delgado, Teresa Valdes
    Perez, Belen Maldonado
    Laria, Luisa Castro
    Charpentier, Cloe
    Arguelles-Arias, Federico
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [22] HLA-DQA1*05:01:11, a novel HLA-DQA1 allele with an ochre stop codon
    Marin Rubio, Luis A.
    Ontanon, Jesus
    HLA, 2023, 101 (05) : 561 - 562
  • [23] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [24] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [25] Characterisation of the first HLA-DQA1 allele with Aspartic Acid in the transmembrane domain, HLA-DQA1*05:71
    Gil-Etayo, Francisco Javier
    Ramirez, Jairo Eduardo Nino
    Hernaz, Isabel Jimenez
    Sanz, Ramon Garcia
    Velarde, Amalia Tejeda
    HLA, 2023, 102 (03) : 381 - 383
  • [26] The novel HLA-DQA1 allele, HLA-DQA1*03:03:05, first described in a Brazilian individual
    Vianna, Romulo
    Lopes, Giovanna
    Secco, Danielle
    Santos, Angela
    Porto, Luis Cristovao
    HLA, 2021, 98 (04) : 407 - 408
  • [27] Impact of the HLA DQA1*05 allele on the efficacy of vedolizumab treatment in inflammatory bowel disease
    Torres, S. Castro
    Cuenca, L. Ramiro
    Rodriguez-Moranta, F.
    Rodriguez-Alonso, L.
    Ruiz-Cerulla, A.
    Sanchez-Pastor, E.
    Anton-Guell, S.
    Capon, J. Guardiola
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1031 - I1031
  • [28] HLA-DQA1*05 detection in saliva, an effective alternative in the monitoring and control of patients with Inflammatory Bowel Disease
    Lavin Exposito, C.
    Bouhmidi Assakali, A.
    Rodriguez Romero, V.
    Cabanillas Navarro, M. L.
    Vozmediano Sanchez, P.
    Velasco del Burgo, M.
    Alanon Barba, M.
    Moraleda Cebrian, F.
    Hidalgo Juarez, M. L.
    Bonillo Merino, C.
    Pinilla Sanchez, J.
    Laguna Laguna, M. T.
    Saluena Saluena, I.
    Sanchez Pardo, A. M.
    Sanchez Alonso, M.
    Suarez, E. Barreto
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2227 - I2227
  • [29] HLA-DQA1*05 or HLA-DQB1*02 allele, compatible genetics celiac disease?
    Jimenez Jimenez, J.
    Asensio Anton, J.
    O'valle Aisa, V.
    Gonzalez Cervera, M. R.
    CLINICA CHIMICA ACTA, 2019, 493 : S578 - S578
  • [30] Characterisation of the Novel HLA-DQA1*05:05:24 Allele by Next Generation Sequencing
    Lion, Julien
    Da Costa, Cecilia
    Guillaume, Nicolas
    Desoutter, Judith
    HLA, 2025, 105 (02)
12345